Bexarotene derivatives and their use in treating cancer
US12338214B2 · kind B2 · utility
0Cited by
1References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 1, 2019 |
| Grant date | Jun 24, 2025 |
| Priority date | — |
| Expiry date | Jan 30, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of the invention, such as compounds of formula (I): where R, R1, R2, R3, R4, R5, R6, and R7 are defined herein, are useful for treating cancer, autoimmune disorders, and/or skin dermatitis, and/or methods for increasing peripheral blood counts and/or improving immune system function. Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.